Alzheimer's diagnostics: Can a blood test change the clinical pathway? Blood-ba…

Alzheimer's diagnostics: Can a blood test change the clinical pathway?

Blood-based biomarkers are advancing the diagnostic work-up of Alzheimer's disease. However, their clinical utility depends on appropriate patient selection, test performance, interpretation and integration into established diagnostic pathways.

For HCPs, the key question is not simply whether a biomarker can detect pathology, but how its result should influence clinical decisions.

Explore the evidence: https://pmc.ncbi.nlm.nih.gov/articles/PMC12306682/

#AlzheimersDisease #Neurology #Biomarkers #PrecisionDiagnostics